Auna Reports Preliminary Key Performance Indicators for the Third Quarter ended September 30, 2026

Hospital activity rose year over year across all three countries, while OncoSalud memberships fell from the second quarter.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Third Quarter ended September 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna.

Healthcare Services Mexico
Key Operating Metrics				3Q'25		4Q'25		1Q'26		2Q'26		3Q'26
Emergency treatments (1)		#		7,274		8,002		7,864		7,892		7,961
Surgeries (2)		#		5,177		5,028		4,855		5,193		5,807
Total number of days hospitalized (3)		#		25,450		24,156		25,122		25,169		26,748
Total Capacity Utilization (4)		%		39.1%		37.1%		39.4%		39.1%		41.1%
Chemotherapies & Radiotherapies (sessions) (5)		#		3,678		3,983		4,162		4,994		4,945
Healthcare Services Peru
Key Operating Metrics				3Q'25		4Q'25		1Q'26		2Q'26		3Q'26
Emergency treatments (1)		#		49,049		47,885		45,485		51,769		53,813
Surgeries (2)		#		5,034		4,973		5,851		5,552		6,107
Total number of days hospitalized (3)		#		30,237		29,541		30,242		31,373		31,940
Total Capacity Utilization (4)		%		85.4%		83.4%		86.4%		88.6%		89.2%
Chemotherapies & Radiotherapies (sessions) (5)		#		11,622		12,909		13,371		12,957		13,697
OncoSalud Peru
Key Operating Metrics				3Q'25		4Q'25		1Q'26		2Q'26		3Q'26
Plan Memberships (6)		#		1,395,509		1,424,695		1,439,781		1,472,019		1,441,794
Healthcare Services Colombia
Key Operating Metrics				3Q'25		4Q'25		1Q'26		2Q'26		3Q'26
Emergency treatments (1)		#		37,323		35,289		38,077		38,196		39,483
Surgeries (2)		#		11,209		10,443		10,904		11,167		12,018
Total number of days hospitalized (3)		#		80,176		79,349		80,716		81,558		85,353
Total Capacity Utilization (4)		%		77.1%		76.3%		79.3%		79.2%		80.3%
Protected lives (7)		#		3,027,499		3,036,335		3,057,763		3,143,694		3,208,686
Chemotherapies & Radiotherapies (sessions) (5)		#		36,668		35,941		36,619		35,346		36,797

1) Emergency care includes the number of visits to the emergency rooms and may include several visits per patient.

2) Number of surgeries includes inpatient surgeries, outpatient surgeries and cesarean sections.

3) Total number of days during which any of Auna's beds were occupied by a hospitalized patient during the period, including ICU.

4) Total capacity utilization is calculated as (i) (x) total number of days in which any of Auna's beds had a hospitalized patient during the period divided by (y) total number of beds, times (ii) total number of days during the period.

5) Intravenous chemotherapy and radiotherapy infusions in both inpatient and outpatient care; excludes oral treatments. In Peru, includes sessions across the Healthcare Services Network and OncoSalud Segments.

6) As of period end and as reported to the National Superintendence of Health Susalud in Peru.

7) Insured population assigned to Auna under risk-sharing agreements in Colombia.

About Auna

Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of September 30, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,361 beds and 1.4 million health plan members.

Preliminary Information

The information contained in this press release is preliminary in nature and is provided for informational purposes only. It is based on current estimates, assumptions, and expectations, which remain subject to ongoing review, verification, and possible revision. Final third quarter ended September 30, 2026 Key Performance Indicators may differ from those set forth herein. Readers are cautioned not to place undue reliance on these preliminary results.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about our intention to publish these key performance indicators on a quarterly basis. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange Commission, including its annual report filed on Form 20-F on April 22, 2026.

The forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261014035676/en/

contact@aunainvestors.com

Source: Auna S.A.

Key Terms

intravenous chemotherapy medical

Intravenous chemotherapy is cancer medication given directly into a vein so the drug quickly enters the bloodstream and circulates through the body. Think of it as delivering medicine via a main highway rather than a local road: it reaches tumors systemwide and is typically administered in a clinic or hospital. For investors, the route of administration matters because it affects treatment costs, provider settings, required equipment, patient convenience, reimbursement, and the competitive position of drug formulations and delivery technologies.

radiotherapy medical

Radiotherapy is a medical treatment that uses targeted high-energy radiation to shrink or destroy tumors and control disease, similar to using a focused beam to remove weeds without digging up the whole garden. It matters to investors because approvals, new technologies, clinical trial results, or changes in treatment guidelines can affect demand for equipment, drug combinations, and patient outcomes, which in turn influence revenue and growth prospects for healthcare companies.

icu medical

An ICU, or intensive care unit, is a hospital ward equipped and staffed to monitor and treat patients with life‑threatening illnesses or injuries that require constant attention and advanced medical support, like breathing machines or continuous medication. For investors, ICU capacity and related costs matter because high demand can signal increased use of hospital services, drive revenue for medical device and healthcare providers, strain a facility’s resources and margins, and influence regulatory and reimbursement pressures—similar to how a factory’s production line affects a manufacturer’s output and costs.

risk-sharing agreements financial

An agreement where two or more parties—often a drugmaker and a payer or insurer—share the financial outcomes of a product or project so that costs, revenues, or risks are divided according to pre-set terms. Investors care because these deals can reduce a company’s exposure to uncertain sales or performance, smoothing revenue swings and protecting margins much like a co-op insurance policy that limits how much any single member loses if something goes wrong.